Ownership rights to tissue donated for research end when the tissue leaves the body, as does all claim to benefit from commercial cell lines or other products derived from the tissue.
A recent journal article proposes a gender-sensitive approach to pain management that acknowledges men's and women's differing needs for pain treatment.